Cite
APA Citation
Cahn, A., Wiviott, S. D., Mosenzon, O., Murphy, S. A., Goodrich, E. L., Yanuv, I., Rozenberg, A., Wilding, J. P. H., Leiter, L. A., Bhatt, D. L., McGuire, D. K., Litwak, L., Kooy, A., Gause‐Nilsson, I. A. M., Fredriksson, M., Langkilde, A. M., Sabatine, M. S., & Raz, I. (2021). cardiorenal outcomes with dapagliflozin by baseline glucose‐lowering agents: Post hoc analyses from DECLARE‐TIMI 58. Diabetes, obesity & metabolism, 23(1), 29–38. http://access.bl.uk/ark:/81055/vdc_100115312354.0x00001b